Public Consultation

The National Blood Authority (NBA) periodically undertakes public consultations. The NBA welcomes comments from individuals or groups on topics in the required formats and timeframes.

Supply of Imported Plasma and Recombinant Products – Future Arrangements

Under the national blood arrangements administered by the NBA, Australia imports a range of plasma derived and recombinant products.  The NBA last tendered for a range of imported plasma derived and recombinant products (IPRP) products in 2014. The initial term of some of these Products expire during the next few years.

The NBA is currently conducting consultations with suppliers and stakeholders via a Request for Information (RFI) and stakeholder consultation paper to inform forward decision making.

Stakeholder Consultation Paper

The NBA is seeking information from stakeholders on a range of issues relevant to the IPRP Products.

Request for Information

The NBA is also seeking information from industry to inform decisions to extend current IPRP contracts or conduct a Request for Tender.

To view outcomes from previous consultations visit Closed Public Consultations.